Benjamin J. Hindson, See Remarks at 10x Genomics, Inc. (TXG), sold 360 shares at $78.59 ($28K) on 2022-02-22, disclosed to the SEC on 2022-02-24.
Open-market sale of $28k TXG by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXG | SELL | 2026-02-25 | $145K | — | Filing → |
| TXG | SELL | 2025-11-25 | $157K | — | Filing → |
| TXG | SELL | 2025-08-26 | $206K | — | Filing → |